vitreoretinal diseases
Conditions
Interventions
Collection of 0.5ml of undiluted vitreous fluid before starting vitrectomy for rhegmatogenous retinal detachment.
Collection of 0.5ml of undiluted vitreous fluid before starting vitrectomy for macular
Sponsors
Department of Ophthalmology, Hirosaki University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with various vitreoretinal diseases which need to be treated by vitreous surgery.
Exclusion criteria
Exclusion criteria: Patients who were previously undergone vitrectomy surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in the antioxidant potentials and cytokine profiles between various vitreoretinal diseases | — |
Secondary
| Measure | Time frame |
|---|---|
| Characteristic patterns of the antioxidant potentials and cytokine profiles in each of various vitreoretinal diseases | — |
Countries
Japan
Contacts
Public ContactMitsuru Nakazawa
Hirosaki University Graduate school of Medicine Department of Ophthalmology
Outcome results
None listed